These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25153017)

  • 1. An update on cardio-oncology.
    Herrmann J; Lerman A
    Trends Cardiovasc Med; 2014 Oct; 24(7):285-95. PubMed ID: 25153017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-Oncology Education and Training: JACC Council Perspectives.
    Alvarez-Cardona JA; Ray J; Carver J; Zaha V; Cheng R; Yang E; Mitchell JD; Stockerl-Goldstein K; Kondapalli L; Dent S; Arnold A; Brown SA; Leja M; Barac A; Lenihan DJ; Herrmann J;
    J Am Coll Cardiol; 2020 Nov; 76(19):2267-2281. PubMed ID: 33153587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-oncology: Concepts and practice.
    Cubbon RM; Lyon AR
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S77-85. PubMed ID: 27056658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need.
    Moslehi J; Fujiwara K; Guzik T
    Cardiovasc Res; 2019 Apr; 115(5):819-823. PubMed ID: 30888396
    [No Abstract]   [Full Text] [Related]  

  • 5. The Burgeoning Field of Cardio-Oncology.
    Trachtenberg BH
    Methodist Debakey Cardiovasc J; 2019; 15(4):241-242. PubMed ID: 31988683
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardio-oncology: an ongoing evolution.
    Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
    Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular medicine and cardio-oncology - A new, evolving clinical frontier.
    Versmissen J; Power JR; Moslehi J
    Vasc Med; 2020 Jun; 25(3):205-207. PubMed ID: 32539631
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Directions in Cardio-Oncology.
    Trachtenberg BH
    Methodist Debakey Cardiovasc J; 2019; 15(4):300-302. PubMed ID: 31988691
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of cardio-oncology.
    Nebigil CG; Désaubry L
    Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.
    Raschi E; De Ponti F
    Intern Emerg Med; 2012 Apr; 7(2):113-31. PubMed ID: 22161318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-oncology, Immuno-oncology, Onco-cardiology and Onco-immunology.
    Kounis NG; Koniari I; Hahalis G
    Int J Cardiol; 2016 Nov; 223():254-257. PubMed ID: 27541667
    [No Abstract]   [Full Text] [Related]  

  • 17. The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters".
    Abe J; Martin JF; Yeh ET
    Circ Res; 2016 Sep; 119(8):896-9. PubMed ID: 27688305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and proposal for cardio-oncology services in Italy.
    Galderisi M; Santoro C; Bossone E; Mancusi C
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):207-215. PubMed ID: 32858628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology.
    Albini A; Donatelli F; Noonan D; D'Elios MM; Prisco D
    Intern Emerg Med; 2012 Apr; 7(2):99-101. PubMed ID: 22271393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.